1
|
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.
|
Eur Urol
|
2006
|
7.13
|
2
|
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.
|
BJU Int
|
2011
|
3.28
|
3
|
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
|
BJU Int
|
2008
|
3.02
|
4
|
Advanced maternal age and adverse perinatal outcome.
|
Obstet Gynecol
|
2004
|
3.01
|
5
|
Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States.
|
Eur Urol
|
2011
|
2.81
|
6
|
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study.
|
BJU Int
|
2009
|
2.63
|
7
|
Symptom bother and health care-seeking behavior among individuals with overactive bladder.
|
Eur Urol
|
2008
|
2.41
|
8
|
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
|
Eur Urol
|
2009
|
2.33
|
9
|
National community prevalence of overactive bladder in the United States stratified by sex and age.
|
Urology
|
2011
|
2.18
|
10
|
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.
|
BMJ
|
2007
|
1.97
|
11
|
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.
|
Eur Urol
|
2012
|
1.95
|
12
|
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
|
Contraception
|
2006
|
1.90
|
13
|
A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
|
Eur Urol
|
2009
|
1.86
|
14
|
Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins.
|
Urology
|
2011
|
1.59
|
15
|
A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century.
|
Menopause
|
2002
|
1.57
|
16
|
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
|
BJU Int
|
2006
|
1.50
|
17
|
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ).
|
Eur Urol
|
2006
|
1.43
|
18
|
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS.
|
BJU Int
|
2009
|
1.40
|
19
|
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
|
BJU Int
|
2011
|
1.38
|
20
|
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women.
|
Am J Obstet Gynecol
|
2003
|
1.37
|
21
|
Economic burden of urgency urinary incontinence in the United States: a systematic review.
|
J Manag Care Pharm
|
2014
|
1.36
|
22
|
The economic impact of overactive bladder syndrome in six Western countries.
|
BJU Int
|
2009
|
1.29
|
23
|
Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years.
|
Eur Urol
|
2010
|
1.20
|
24
|
Hormonal contraception and venous thromboembolism.
|
Acta Obstet Gynecol Scand
|
2012
|
1.20
|
25
|
Understanding the elements of overactive bladder: questions raised by the EPIC study.
|
BJU Int
|
2008
|
1.12
|
26
|
Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.
|
Acta Obstet Gynecol Scand
|
2003
|
1.12
|
27
|
Evidence for a secular trend in menopausal age: a population study of women in Gothenburg.
|
Menopause
|
2003
|
1.12
|
28
|
A review of adherence to drug therapy in patients with overactive bladder.
|
BJU Int
|
2008
|
1.06
|
29
|
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
|
Acta Obstet Gynecol Scand
|
2002
|
1.06
|
30
|
The current and future burden and cost of overactive bladder in five European countries.
|
Eur Urol
|
2006
|
1.06
|
31
|
Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years.
|
Acta Obstet Gynecol Scand
|
2002
|
1.05
|
32
|
Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review.
|
Eur Urol
|
2010
|
1.04
|
33
|
Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
|
Int J Cancer
|
2013
|
1.03
|
34
|
The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder.
|
BJU Int
|
2011
|
1.03
|
35
|
Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
|
Cancer
|
2007
|
0.99
|
36
|
Overactive bladder syndrome in older people.
|
BJU Int
|
2007
|
0.99
|
37
|
Overactive bladder: Is there a link to the metabolic syndrome in men?
|
Neurourol Urodyn
|
2010
|
0.98
|
38
|
Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.
|
Int J Cancer
|
2013
|
0.98
|
39
|
Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?
|
Eur J Cancer
|
2007
|
0.95
|
40
|
Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men.
|
J Sex Med
|
2008
|
0.95
|
41
|
Oestrogens and overactive bladder.
|
Neurourol Urodyn
|
2013
|
0.94
|
42
|
UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction?
|
Int Urogynecol J
|
2014
|
0.93
|
43
|
The performance of a new scoring system for colposcopy in detecting high-grade dysplasia in the uterine cervix.
|
Acta Obstet Gynecol Scand
|
2005
|
0.93
|
44
|
The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS.
|
Neurourol Urodyn
|
2013
|
0.93
|
45
|
Can we prevent incontinence? ICI-RS 2011.
|
Neurourol Urodyn
|
2012
|
0.91
|
46
|
Rationale for the study methods and design of the epidemiology of lower urinary tract symptoms (EpiLUTS) study.
|
BJU Int
|
2009
|
0.90
|
47
|
Genetics and the lower urinary tract.
|
Neurourol Urodyn
|
2010
|
0.90
|
48
|
Short- and long-term results of the tension-free vaginal tape procedure in the treatment of female urinary incontinence.
|
Acta Obstet Gynecol Scand
|
2006
|
0.90
|
49
|
Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.
|
Fertil Steril
|
2008
|
0.89
|
50
|
Examining lower urinary tract symptom constellations using cluster analysis.
|
BJU Int
|
2008
|
0.88
|
51
|
Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population.
|
Contraception
|
2009
|
0.87
|
52
|
Expectant management of first-trimester miscarriage in clinical practice.
|
Acta Obstet Gynecol Scand
|
2003
|
0.86
|
53
|
The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study.
|
Hum Reprod
|
2012
|
0.86
|
54
|
Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL.
|
Contraception
|
2007
|
0.85
|
55
|
The long-term influence of combined oral contraceptives on body weight.
|
Hum Reprod
|
2011
|
0.85
|
56
|
Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins.
|
Eur Urol
|
2011
|
0.85
|
57
|
Low persistence of anticholinergic drug use in Sweden.
|
Eur J Clin Pharmacol
|
2011
|
0.85
|
58
|
The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample.
|
Eur Urol
|
2010
|
0.83
|
59
|
The impact of OAB on sexual health in men and women: results from EpiLUTS.
|
J Sex Med
|
2011
|
0.83
|
60
|
Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007.
|
BJU Int
|
2009
|
0.83
|
61
|
Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
|
Acta Obstet Gynecol Scand
|
2005
|
0.81
|
62
|
Maternal fatalities, fetal and neonatal deaths related to motor vehicle crashes during pregnancy: a national population-based study.
|
Acta Obstet Gynecol Scand
|
2008
|
0.81
|
63
|
The influence of the modifiable life-style factors body mass index and smoking on the outcome of mid-urethral sling procedures for female urinary incontinence.
|
Int Urogynecol J
|
2015
|
0.80
|
64
|
Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
|
BJOG
|
2006
|
0.79
|
65
|
Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.
|
BJU Int
|
2011
|
0.79
|
66
|
Faecal incontinence 20 years after one birth: a comparison between vaginal delivery and caesarean section.
|
Int Urogynecol J
|
2014
|
0.79
|
67
|
The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study.
|
Hum Reprod
|
2013
|
0.78
|
68
|
[Increasing number of Chlamydia infections--how can we reverse this trend?].
|
Lakartidningen
|
2002
|
0.78
|
69
|
Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.
|
Acta Obstet Gynecol Scand
|
2007
|
0.78
|
70
|
A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century.
|
Hum Reprod
|
2010
|
0.78
|
71
|
Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
|
Neurourol Urodyn
|
2012
|
0.78
|
72
|
Can we predict and prevent pelvic floor dysfunction?
|
Int Urogynecol J
|
2015
|
0.77
|
73
|
Clustering of pelvic floor disorders 20 years after one vaginal or one cesarean birth.
|
Int Urogynecol J
|
2015
|
0.77
|
74
|
Cervical cancer screening--"For better or worse...": women's experience of screening.
|
Cancer Nurs
|
2006
|
0.76
|
75
|
Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women.
|
Blood Press
|
2010
|
0.76
|
76
|
Comparison of health care costs for open Burch colposuspension, laparoscopic colposuspension and tension-free vaginal tape in the treatment of female urinary incontinence.
|
Neurourol Urodyn
|
2007
|
0.75
|
77
|
Editorial comment.
|
Urology
|
2010
|
0.75
|
78
|
Maternal birth trauma: why should it matter to urogynaecologists?
|
Curr Opin Obstet Gynecol
|
2016
|
0.75
|
79
|
[Increasing number of teenage pregnancies--multicultural approach in the preventive work is needed].
|
Lakartidningen
|
2003
|
0.75
|
80
|
The cervical cancer screening program from a midwife's perspective.
|
Acta Obstet Gynecol Scand
|
2007
|
0.75
|
81
|
A three-armed randomized trial comparing open Burch colposuspension using sutures with laparoscopic colposuspension using sutures and laparoscopic colposuspension using mesh and staples in women with stress urinary incontinence.
|
Acta Obstet Gynecol Scand
|
2005
|
0.75
|
82
|
A randomised trial comparing open Burch colposuspension using sutures with laparoscopic colposuspension using mesh and staples in women with stress urinary incontinence.
|
BJOG
|
2004
|
0.75
|
83
|
Acute effects of transdermal 17beta-estradiol on hemostatic variables after 24-hour treatment.
|
Clin Appl Thromb Hemost
|
2002
|
0.75
|
84
|
Influence of age and changes over time on erectile dysfunction: results from two large cross-sectional surveys 11 years apart.
|
Scand J Urol
|
2012
|
0.75
|
85
|
Influence of chronic hormone replacement therapy on left ventricular mass and serum-ACE activity.
|
Blood Press
|
2010
|
0.75
|
86
|
A focus on important reproductive health care issues - cancer, urinary incontinence and the consequences of pre-term birth.
|
Acta Obstet Gynecol Scand
|
2010
|
0.75
|
87
|
The uterine cervix and the importance of cervical secretions.
|
Acta Obstet Gynecol Scand
|
2009
|
0.75
|